ARCHIVED  July 1, 1997

FTC probes Novartis, Heska deal

By

FORT COLLINS — A huge Swiss pharmaceutical company’s investment in Fort Collins-based Heska Corp. has prompted a probe by the Federal Trade Commission for possible violations of antitrust laws.

Novartis AG’s predecessor invested $36 million in Heska in April 1996 — an investment not made public at the time — giving it the right to market and manufacture any flea-control vaccine or feline heartworm-control vaccine developed by Heska, which produces vaccines for companion animals.

The FTC investigation was revealed in a May 30 amendment to Heska’s registration statement with the U.S. Securities and Exchange Commission. Heska filed the initial public offering with…

Christopher Wood
Christopher Wood is editor and publisher of BizWest, a regional business journal covering Boulder, Broomfield, Larimer and Weld counties. Wood co-founded the Northern Colorado Business Report in 1995 and served as publisher of the Boulder County Business Report until the two publications were merged to form BizWest in 2014. From 1990 to 1995, Wood served as reporter and managing editor of the Denver Business Journal. He is a Marine Corps veteran and a graduate of the University of Colorado Boulder. He has won numerous awards from the Colorado Press Association, Society of Professional Journalists and the Alliance of Area Business Publishers.
Categories: ARCHIVED Industry News
Sign up for BizWest Daily Alerts
Closing in 8 seconds...